BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20528905)

  • 21. Central nervous system involvement in diffuse large B-cell lymphoma.
    Yamamoto W; Tomita N; Watanabe R; Hattori Y; Nakajima Y; Hyo R; Hashimoto C; Motomura S; Ishigatsubo Y
    Eur J Haematol; 2010 Jul; 85(1):6-10. PubMed ID: 20236301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model.
    Hollender A; Kvaloy S; Nome O; Skovlund E; Lote K; Holte H
    Ann Oncol; 2002 Jul; 13(7):1099-107. PubMed ID: 12176790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
    Lin XB; Zhou NN; Li S; Cai QQ; Xia ZJ; Liao H; Gao Y; Huang HQ
    Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].
    Siepmann K; Rohrbach JM; Duncker G; Zierhut M
    Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.
    Broussalis E; Hutterer M; Oppermann K; Wipfler P; Pilz G; Harrer A; Haschke-Becher E; Golaszewski S; Schönauer U; Weis S; Killer-Oberpfalzer M; Mc Coy M; Trinka E; Kraus J
    Acta Neurol Scand; 2012 Sep; 126(3):e11-6. PubMed ID: 22211863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary CNS lymphoma.
    Gerstner E; Batchelor T
    Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
    Shimada K
    Brain Nerve; 2011 May; 63(5):467-72. PubMed ID: 21515926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
    Papageorgiou SG; Diamantopoulos P; Levidou G; Angelopoulou MK; Economopoulou P; Efthimiou A; Constantinou N; Katsigiannis A; Korkolopoulou P; Pappa V; Economopoulou C; Georgiou G; Dimou M; Tsirigotis P; Kyrtsonis MC; Kotsianidis I; Kalpadakis C; Dimopoulos MA; Beris P; Meletis J; Pangalis GA; Dervenoulas J; Panayiotidis P; Vassilakopoulos TP
    Hematol Oncol; 2013 Mar; 31(1):10-7. PubMed ID: 22610484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
    Tanaka T; Shimada K; Yamamoto K; Hirooka Y; Niwa Y; Sugiura I; Kitamura K; Kosugi H; Kinoshita T; Goto H; Nakamura S
    Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database.
    Kumar A; Vanderplas A; LaCasce AS; Rodriguez MA; Crosby AL; Lepisto E; Czuczman MS; Nademanee A; Niland J; Gordon LI; Millenson M; Zelenetz AD; Friedberg JW; Abel GA
    Cancer; 2012 Jun; 118(11):2944-51. PubMed ID: 22006274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal chemotherapy in lymphomatous meningitis.
    Canova F; Marino D; Trentin C; Soldà C; Ghiotto C; Aversa SM
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):127-34. PubMed ID: 20696592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristic features of malignant lymphoma with central nervous system involvement.
    Yoshida S; Morii K; Watanabe M; Saito T
    Surg Neurol; 2000 Feb; 53(2):163-7. PubMed ID: 10713195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten antibodies, six colors, twelve parameters: a multiparameter flow cytometric approach to evaluate leptomeningeal disease in B-cell non-Hodgkin's lymphomas.
    Stacchini A; Aliberti S; Demurtas A; Benevolo G; Godio L
    Cytometry B Clin Cytom; 2012 May; 82(3):139-44. PubMed ID: 22328059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
    Herrlinger U; Glantz M; Schlegel U; Gisselbrecht C; Cavalli F
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S25-34. PubMed ID: 19660681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome.
    Del Principe MI; Buccisano F; Soddu S; Maurillo L; Cefalo M; Piciocchi A; Consalvo MI; Paterno G; Sarlo C; De Bellis E; Zizzari A; De Angelis G; Fraboni D; Divona M; Voso MT; Sconocchia G; Del Poeta G; Lo-Coco F; Arcese W; Amadori S; Venditti A
    Semin Hematol; 2018 Oct; 55(4):209-214. PubMed ID: 30502849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.
    Gill S; Herbert KE; Prince HM; Wolf MM; Wirth A; Ryan G; Carney DA; Ritchie DS; Davies JM; Seymour JF
    Br J Haematol; 2009 Oct; 147(1):83-8. PubMed ID: 19694718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary central nervous system lymphoma: current state of anti-CD20 therapy and appraisal of reported response criteria.
    Siegal T
    J Clin Neurosci; 2014 May; 21(5):709-15. PubMed ID: 24725453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas.
    Barrena S; Almeida J; Del Carmen García-Macias M; López A; Rasillo A; Sayagués JM; Rivas RA; Gutiérrez ML; Ciudad J; Flores T; Balanzategui A; Caballero MD; Orfao A
    Histopathology; 2011 May; 58(6):906-18. PubMed ID: 21438908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.